Home›Infectious Disease› Magnesium phosphate cements demonstrate superior biological interactions and faster resorption than calcium phosphate cements
Magnesium phosphate cements demonstrate superior biological interactions and faster resorption than calcium phosphate cementsMagnesium Phosphate Cements Show Better Biological Interaction Than Calcium Options
Frontiers in MedicinePublished July 18, 2026Study authors: Nishmitha N. Hegde, Harshitha Somanatha, Chaithra Lakshmi, Niranjan Harikrishna, Mithra N. HegdeDOI ↗Editorial oversight: Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Note that MPCs offer superior resorption and biological interaction over CPCs but lack multicentre clinical trial data.
This mini review evaluates the properties and potential applications of magnesium phosphate cements (MPCs) in endodontic, periodontal, craniofacial, and bone tissue engineering contexts. The authors compare these materials specifically against conventional calcium phosphate cements (CPCs).
The review synthesizes evidence indicating that MPCs demonstrate superior biological interactions and faster scaffold resorption compared with CPCs. Additionally, the review notes that MPCs are characterized by rapid setting, high early mechanical strength, biodegradability, osteogenic potential, and intrinsic antimicrobial activity.
Several limitations are noted regarding the practical application of these materials. Specifically, certain formulations may cause exothermic setting reactions or ammonia release in ammonium-containing versions. Furthermore, the authors highlight a lack of robust multicentre clinical trial data to support widespread clinical translation.
Clinically, MPCs are identified as promising candidates for various dental and bone tissue engineering applications. However, practitioners should note that current evidence is largely preclinical, and the transition to standard clinical practice is currently limited by the absence of large-scale human trials.
How this fits prior evidence
This review addresses a gap in material science for endodontic and periodontal conditions. While prior coverage established associations between periodontal disease and systemic conditions such as Alzheimer's disease (2.67 odds ratio), pancreatic cancer, oral cancer, and frailty risk in older adults, this review focuses on the physical and biological properties of bone graft materials like MPCs to treat these underlying conditions.
This review looked at the differences between magnesium phosphate cements (MPCs) and standard calcium phosphate cements (CPCs). These materials are used in dental procedures, such as treating gum disease or repairing bone defects. The study compared how these two types of cement behave when placed in the body.
The findings suggest that magnesium phosphate cements have better biological interactions than traditional calcium options. They also showed faster scaffold resorption, which means the material breaks down more effectively to allow for new tissue growth. These properties make them promising candidates for various dental and bone engineering uses.
While these results are encouraging, there are important factors to consider before they can be used widely in clinics. Some formulations can cause heat during setting or release ammonia. Additionally, because the current evidence comes from a review of existing data rather than large multi-center clinical trials, more human testing is needed to confirm these benefits for patients.
What this means for you:
Magnesium phosphate cements show promise for bone and dental repair but need more clinical trials to be confirmed.
Common questions
What makes magnesium phosphate cement different from standard options?
Magnesium phosphate cements (MPCs) show superior biological interactions and faster scaffold resorption compared to conventional calcium phosphate cements (CPCs). This means they may integrate better with the body's tissues and break down more effectively during the healing process in dental or bone procedures.
Are there any risks associated with using these materials?
Some formulations of magnesium phosphate cements can cause exothermic setting reactions, which means they release heat. Additionally, some versions containing ammonium may release ammonia during the setting process. These factors are important considerations for their use in clinical settings.
Can these materials be used for various dental conditions?
These cements are considered promising candidates for several uses, including endodontic conditions, periodontal disease, and craniofacial defects. They may also be useful in bone tissue engineering because of their potential for better biological interaction.
Magnesium phosphate cements (MPCs) are emerging biomaterials in regenerative dentistry, offering rapid setting, high early mechanical strength, biodegradability, osteogenic potential, and intrinsic antimicrobial activity. Compared with conventional calcium phosphate cements (CPCs), MPCs demonstrate superior biological interactions and faster scaffold resorption, positioning them as promising candidates for endodontic, periodontal, craniofacial, and bone tissue engineering applications. This Mini Review critically appraises the chemistry, biological properties, clinical applications, and translational challenges of MPCs, highlighting current evidence gaps and emerging research directions. While preclinical evidence is encouraging, exothermic setting reactions, ammonia release in ammonium-containing formulations, and the absence of robust multicentre clinical trial data remain the principal barriers to widespread adoption. Advances in formulation engineering, additive manufacturing, and composite scaffold design represent the most promising avenues for addressing these limitations and facilitating clinical translation.
